Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Zymeworks investor conference participation
Business conference participation

Zymeworks investor conference participation

Analysis based on 6 articles · First reported Aug 11, 2026 · Last updated Aug 11, 2026

Sentiment
0
Attention
0
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The announcement is routine and unlikely to have a significant impact on Zymeworks' stock price. Investor conferences provide opportunities for management to communicate with investors, which may modestly influence sentiment but typically does not move markets.

Biotechnology
Event Summary

Zymeworks Inc., a biotechnology company, announced that its management will participate in several upcoming investor conferences in September 2026. These include the Wells Fargo Healthcare Conference on September 8 in Boston, Citi's Biopharma Back to School Summit on September 9 in New York, the Morgan Stanley Healthcare Conference on September 14 in New York, and the H.C. Wainwright Annual Global Investment Conference on September 15 in New York. At these events, management will engage in one-on-one meetings and fireside chats. The company also highlighted its portfolio of licensed healthcare assets, including Ziihera (zanidatamab-hrii), and its partnerships with BeOne Medicines Ltd. and Jazz Pharmaceuticals Ireland Limited for the development and commercialization of zanidatamab in different territories.

Key Actions
10 Zymeworks announced financial results date
Entities Involved
stock
Zymeworks
Zymeworks is the subject of the announcement, participating in investor conferences to engage with the investment community. This is a routine corporate activity with minimal direct impact on its valuation.
Importance 100.0 Sentiment 0.0
priv
BeOne Medicines
BeOne Medicines is a partner of Zymeworks with exclusive rights to develop and commercialize zanidatamab in certain territories. The conference participation does not directly affect BeOne Medicines.
Importance 20.0 Sentiment 0.0
stock
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a partner of Zymeworks with exclusive rights to develop and commercialize zanidatamab in certain territories. The conference participation does not directly affect Jazz Pharmaceuticals.
Importance 20.0 Sentiment 0.0
stock
Wells Fargo
Wells Fargo is hosting a healthcare conference where Zymeworks will present. This is a standard industry event with no material impact on Wells Fargo.
Importance 10.0 Sentiment 0.0
stock
Citigroup
Citigroup is hosting a biopharma summit where Zymeworks will present. This is a routine conference with no material impact on Citigroup.
Importance 10.0 Sentiment 0.0
stock
Morgan Stanley
Morgan Stanley is hosting a healthcare conference where Zymeworks will present. This is a standard event with no material impact on Morgan Stanley.
Importance 10.0 Sentiment 0.0
priv
H.C. Wainwright & Co.
H.C. Wainwright is hosting an investment conference where Zymeworks will present. This is a routine event with no material impact on the firm.
Importance 10.0 Sentiment 0.0
Relationships
Wells Fargo related ↔ Citigroup
Wells Fargo related ↔ Morgan Stanley
Citigroup related ↔ Morgan Stanley
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.